Vivo Capital, LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$1.4B
Holdings
48
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SVASinovac Biotech Ltd. | 5,900,000 | $615.4T | 42474626.12% | |
| 2 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $91.7T | 6330361.34% | |
| 3 | VRNAVerona Pharma PLC | 4,249,918 | $89.8T | 6201249.38% | |
| 4 | AVDLAvadel Pharmaceuticals PLC | 3,829,577 | $63.1T | 4356138.45% | |
| 5 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $58.3T | 4021101.01% | |
| 6 | GONGeron Corp | 16,524,634 | $53.0T | 3661259.75% | |
| 7 | TARSTarsus Pharmaceuticals Inc | 2,262,200 | $40.9T | 2821517.91% | |
| 8 | VRDNViridian Therapeutics Inc | 1,678,207 | $39.9T | 2755710.79% | |
| 9 | —VectivBio Holding AG | 2,333,300 | $39.4T | 2716935.48% | |
| 10 | 290AChinook Therapeutics Inc | 934,879 | $35.9T | 2479170.66% | |
| 11 | ALXOALX Oncology Holdings Inc | 4,220,048 | $31.7T | 2187514.71% | |
| 12 | COGTCogent Biosciences Inc | 2,244,941 | $26.6T | 1834637.59% | |
| 13 | —Icosavax, Inc. | 1,704,568 | $16.9T | 1168307.69% | |
| 14 | GRCLGracell Biotechnologies Inc | 3,969,427 | $15.1T | 1043870.10% | |
| 15 | CATBUSDAstria Therapeutics Inc | 1,681,199 | $14.0T | 966624.49% | |
| 16 | VTYXVentyx Biosciences Inc | 422,075 | $13.8T | 955558.18% | |
| 17 | ACLXArcellx Inc. | 433,785 | $13.7T | 946738.56% | |
| 18 | ALLKGUSDAllakos Inc | 2,988,000 | $13.0T | 899209.20% | |
| 19 | ZLABZai Lab Ltd ADR | 445,505 | $12.4T | 852699.73% | |
| 20 | OLMAOlema Pharmaceuticals Inc | 1,339,271 | $12.1T | 834737.40% | |
| 21 | VSTMVerastem Inc | 1,538,461 | $11.4T | 790047.30% | |
| 22 | CMPXCompass Therapeutics Inc | 3,556,023 | $11.3T | 780522.34% | |
| 23 | —Aslan Pharmaceuticals Ltd | 2,840,908 | $10.4T | 715720.88% | |
| 24 | NVLSEURAlpine Immune Sciences Inc | 914,913 | $9.4T | 649182.18% | |
| 25 | ACRSAclaris Therapeutics, Inc. | 898,631 | $9.3T | 643211.49% | |
| 26 | AMRSEURAmyris, Inc | 7,750,828 | $8.0T | 551034.76% | |
| 27 | KALVKalVista Pharmaceuticals Inc. | 856,008 | $7.7T | 531757.95% | |
| 28 | —Genetron Holdings Ltd | 8,124,174 | $7.6T | 521557.88% | |
| 29 | TILInstil Bio Inc | 12,486,787 | $6.9T | 474893.24% | |
| 30 | DCTHDelcath Systems, Inc. | 1,178,787 | $6.9T | 474348.51% | |
| 31 | DYNDyne Therapeutics Inc | 577,642 | $6.5T | 448543.93% | |
| 32 | WHWKAadi Bioscience Inc | 509,572 | $6.5T | 445631.43% | |
| 33 | SERASera Prognostics Inc | 1,856,011 | $6.1T | 422113.86% | |
| 34 | IOBTIO Biotech Inc | 3,015,545 | $5.9T | 406917.34% | |
| 35 | —DBV Technologies SA | 2,708,875 | $5.1T | 355251.79% | |
| 36 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $5.0T | 342026.22% | |
| 37 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $4.9T | 338217.81% | |
| 38 | IOVAIovance Biotherapeutics Inc | 655,057 | $4.6T | 318306.41% | |
| 39 | CLNNEURClene Inc | 4,520,622 | $3.7T | 255861.95% | |
| 40 | —Impel NeuroPharma Inc | 2,884,789 | $3.7T | 252878.22% | |
| 41 | ALGSAligos Therapeutics Inc | 3,547,030 | $3.4T | 237726.58% | |
| 42 | BCABBioAtla Inc | 637,181 | $1.9T | 131940.38% | |
| 43 | FULCFulcrum Therapeutics Inc | 550,000 | $1.8T | 125276.70% | |
| 44 | IMUXImmunic Inc | 632,184 | $1.6T | 109524.41% | |
| 45 | CDXSCodexis, Inc | 388,144 | $1.1T | 75014.37% | |
| 46 | RZLTRezolute Inc | 489,473 | $969.2B | 66894.10% | |
| 47 | FIXXEURHomology Medicines, Inc. | 370,068 | $327.5B | 22605.71% | |
| 48 | DTILPrecision Biosciences Inc | 140,255 | $73.8B | 5092.10% |